A detailed history of Richard Bernstein Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Richard Bernstein Advisors LLC holds 34,226 shares of ABBV stock, worth $6.16 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
34,226
Previous 36,603 6.49%
Holding current value
$6.16 Million
Previous $6.28 Million 7.65%
% of portfolio
0.15%
Previous 0.15%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$163.84 - $199.33 $389,447 - $473,807
-2,377 Reduced 6.49%
34,226 $6.76 Million
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $928 - $1,084
6 Added 0.02%
36,603 $6.28 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $3,835 - $4,370
24 Added 0.07%
36,597 $6.66 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $4.81 Million - $5.56 Million
-35,982 Reduced 49.59%
36,573 $5.45 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $899,609 - $1.03 Million
-6,703 Reduced 8.46%
72,555 $9.74 Million
Q2 2022

Aug 02, 2022

BUY
$137.62 - $174.96 $7.68 Million - $9.76 Million
55,791 Added 237.74%
79,258 $12.1 Million
Q1 2022

May 12, 2022

BUY
$131.98 - $163.75 $1.5 Million - $1.86 Million
11,331 Added 93.37%
23,467 $3.8 Million
Q3 2021

Nov 09, 2021

BUY
$106.4 - $120.78 $243,336 - $276,223
2,287 Added 23.22%
12,136 $1.31 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $2.78 Million - $4.22 Million
-43,172 Reduced 81.42%
9,849 $750,000
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $511,964 - $615,527
-8,129 Reduced 13.29%
53,021 $4.01 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $4.75 Million - $5.28 Million
53,409 Added 689.95%
61,150 $5.78 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $214,574 - $253,889
2,390 Added 44.66%
7,741 $717,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $479,235 - $525,521
5,351
5,351 $518,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Richard Bernstein Advisors LLC Portfolio

Follow Richard Bernstein Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard Bernstein Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Richard Bernstein Advisors LLC with notifications on news.